【欢迎正在创业以及寻求融资的公司和寻找合适项目的投资机构联系我们，大家可以一起合作、交流、资源对接、互通有无或者创造更多无限可能，为保证真实性和效率，联系我们时请备注公司+姓名，无关人员请不要添加】 猛兽财经获悉，美国生物技术研发 ...

在冠状病毒大流行期间，由麻省理工学院本科生创办的生物技术研发软件初创公司Benchling估值升至8.5亿美元。 Sajith Wickramasekara八年前在麻省理工学院读大学的时候就开始为科学家们研究基于云的Crispr设计工具。如今，Regeneron、Gilead和其他生物科技巨头的研究人员 ...

路透社11月18日消息，知情人士称，为科学家和医药研究机构开发软件工具的初创企业Benchling已向监管机构秘密提交在纽交所上市的文件。 据悉，这家总部位于加州旧金山的公司在今年早些时候的一轮融资中估值为40亿美元，其目标是在2022年初以更高的估值上市。

一位90后小伙子正在准备走向纽交所。 2021年11月，Benching完成了1亿美元F轮融资，公司估值达61亿美元。此后，Benchling计划在2022年上市的消息便不绝于耳。 2012年，年仅22岁的Sajith Wickramasekara基于自身的研究经历，在麻省理工学院实验室中看到了商机：为科学家和 ...

SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...

Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.

Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /CNW/ -- Benchling today unveiled major new capabilities at ...

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

We spotlight trailblazers in the entrepreneurship world, exploring their groundbreaking ventures, innovative strategies, and the latest trends shaping the business landscape. Fresh new ideas and ...

On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...

SAN FRANCISCO--(BUSINESS WIRE)--Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round ...